Clinical experience suggests good tolerability, with: Mild injection site reactions Occasional digestive changes (particularly with oral administration) Rarely reported headache Important Safety Considerations Both peptides should be prescribed and monitored by qualified medical providers Quality of peptide sourcing matters compounding pharmacies should be licensed and regulated Lab monitoring (particularly IGF-1 for sermorelin) is essential for ongoing safety Contraindications (active malignancies, certain medical conditions) must be evaluated Medical Disclaimer Sermorelin was previously FDA-approved for diagnostic use (Geref Diagnostic) and is currently prescribed off-label through compounding pharmacies
MMPs, particularly MMP-9, and proteins such as HMGB1 have also been implicated in BBB breakdown, highlighting the need for further research into these pathways as potential therapeutic targets for AD [184,203,204]
Kaempferol prevents acetaminophen-induced liver injury by suppressing hepatocyte ferroptosis via Nrf2 pathway activation
Welcome to the new frontier of self-optimization
The fact that GSH depletion is one of the earliest brain abnormalities in Parkinsons has led to several studies assessing the effects of intranasal GSH supplementation in that disease
(PubMed) Age-Related Eye Disease Study 2 Research Group
